What type of drug is Bavencio?
Official Answer
by Drugs.comBavencio (avelumab) is a programmed death ligand-1 (PD-L1) blocking antibody.
Bavencio targets the PD-L1 receptors, which are protein receptors on cell surfaces. When Bavencio blocks PD-L1, it 'turns on' the ability of cancer-fighting cells such as T-cells to attack and kill tumors.
Learn More: Checkpoint Inhibitors & Advanced Cancers: A Health Care Professional's Guide
Bavencio is used for the treatment of:
- Merkel Cell Carcinoma (MCC)
- Urothelial Carcinoma (UC)
- Renal Cell Carcinoma (RCC)
References
- Bavencio (avelumab) [product information]. EMD Serono, Inc.
Rockland, MA. Accessed Feb. 20, 2021 at https://www.emdserono.com/us-en/pi/bavencio-pi.pdf
Related Medical Questions
Drug Information
Related Support Groups
- Avelumab (2 questions, 3 members)
- Bavencio (2 questions, 3 members)
- Renal Cell Carcinoma (20 questions, 94 members)
- Urothelial Carcinoma (6 questions, 3 members)
- Merkel Cell Carcinoma (4 questions, 3 members)